INFU InfuSystem Holdings, Inc.
XASE
14.70
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
INFU
$14.70
—
What changed
Recent filings, trades and movesKey stats
$14.70
- 52-Week Range
- $7.29 – $14.79
- YTD
- +75.17%
- IV Rank (30D)
- 24.79
- Straddle Price
- $2.20
- P/C Vol Ratio
- 0.21
- Market Cap
- $0.3B
- Open
- $14.08
- Day Range
- $13.69 – $14.79
- Volume
- 130,088
- Prev Close
- $13.69
Fair Value
MODEL: NEUTRAL
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.90% |
| Beta vs SPY | 1.12 |
| Cost of Equity (CAPM) | 11.04% (VRP-adj) |
| WACC | 10.67% |
| Volatility Risk Premium | +69.8pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 30.0% |
| Rev. Growth (YoY, DCF input) | +1.2% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.01 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.0B |
| Return on Equity (TTM) | 14.4% |
| Book / Price | 20.7% |
| Gross Margin (TTM) | 57.5% |
| FCF Margin (TTM) | 8.8% |
| Debt / Equity | 0.35 |
| Quality Score | 3/6 — normal (10y DCF) |
| Market-Implied Growth | +14.3% (reverse-DCF on current price) |
| SMA 50 | $13.11 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $13.80 |
| Bollinger Width / SMA20 | 11.4% (drives anchor stability) |
| Net Debt | $0.0B |
| Market Cap | $0B |
Peers used for multiples: AAPL, ABBV, BMY, GILD, GKOS, LGND, LLY, OSCR
60-Day Conviction
24%
20-Day Fair Value
≈ by Dec 8, 2026
$14.52
α -1.2%
rank 82%
conviction
75%
40-Day Fair Value
≈ by Jan 6, 2027
$14.58
α -0.8%
rank 82%
conviction
32%
60-Day Fair Value
≈ by Feb 4, 2027
$14.57
α -0.9%
rank 82%
conviction
24%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $6.07 | 25% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $16.58 | 7% | median 41.0× · 6 peers |
| Peer EV/EBITDA | $33.61 | 7% | median 27.1× · 7 peers |
| Peer P/B | $45.07 | 7% | median 15.9× · 7 peers |
| Peer P/S | $63.01 | 7% | median 9.1× · 8 peers |
| Market Anchor (SMA50) | $13.11 | 46% | stability 93% (BB-width) |
| Options Expected (B-L 30d) | $15.16 | 0% | 5 strikes · skew +0.48 |
As of 2026-11-09 · updated
Related
About
- Industry (SIC)
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
- Exchange
- XASE
- Market Cap
- $0.3B
- Employees
- 473
- List Date
- 1992-12-22
- CIK
- 0001337013
- Last Earnings
- Nov 5 after close · +1.0% vs ±12.0% expected
- Next Earnings
- ~Feb 23, 2027 (estimated)
- Headquarters
- Rochester Hills, MI
- Homepage
- http://www.infusystem.com
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles …
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -5.52% | -13.17% | 15.17% | -9.42% | 0.12% | -1.55% | -2.40% |
| Feb | -3.51% | -23.65% | -11.42% | -2.63% | -1.36% | 6.43% | -6.02% |
| Mar | 12.36% | -13.43% | -18.16% | -7.85% | -25.90% | -0.65% | -8.94% |
| Apr | 8.70% | -19.57% | 22.01% | -14.76% | -11.94% | 8.92% | -1.11% |
| May | -19.28% | 17.93% | -0.91% | -8.23% | 21.68% | -12.54% | -0.23% |
| Jun | 14.11% | 6.41% | 9.93% | -3.12% | 9.86% | 7.82% | 7.50% |
| Jul | -15.08% | 1.03% | 7.72% | 1.02% | -9.39% | -8.32% | -3.84% |
| Aug | -24.24% | -22.04% | 1.68% | 0.61% | 89.12% | 31.78% | 12.82% |
| Sep | -9.58% | -10.15% | -6.13% | 5.85% | -2.08% | 6.53% | -2.59% |
| Oct | 23.64% | 9.47% | -0.83% | -4.62% | 0.88% | 9.75% | 6.38% |
| Nov | 1.10% | 7.92% | 4.15% | 39.28% | -10.77% | 6.21%* | 7.98% |
| Dec | 6.50% | -1.36% | 4.36% | -6.42% | -3.24% | -- | -0.03% |
| Total | -20.58% | -52.23% | 22.97% | -17.62% | 25.90% | 60.41% | 3.14% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $13.85
SMA 50: $13.16
SMA 200: $10.48
Current: $14.72
EMA 12: $13.84
EMA 26: $13.64
MACD: 0.1966 | Signal: -0.0359
BULLISH
ADX (14): 28.35
TREND
+DI: 21.66
−DI: 23.06
Momentum Oscillators
RSI (14): 62.74
NEUTRAL
Stoch %K: 69.76
Stoch %D: 51.69
Williams %R: -2.65
Volume & Volatility
BB Upper: $14.73
BB Lower: $12.97
NEUTRAL
OBV: 5,625,596
Vol SMA 20: 142,909
Vol ROC: 37.57%
ATR: $0.65
True Range: $1.10
HV 20: 50.3%
HV 30: 42.5%
HV 60: 33.4%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-08T00:00:00 – 2026-11-06T00:00:00
AI Analysis
Written before INFU’s Nov 5 earnings report, so it doesn’t reflect the results.
LLM Stock Analysis Report: INFU
Executive Summary
BULLISH (Confidence Level: 8/10)
Key drivers:
- Strong technical signals, including MACD's bullish crossover and RSI's overbought reading
- Positive recent news headlines highlighting company performance and market growth
Primary risks:
- High volatility, indicated by beta value of 1.32
- Potential for a pullback or consolidation period following the recent price move
Investment thesis: INFU is poised to continue its upward trend due to strong technical signals and positive news sentiment. However, caution should be exercised given the high volatility and potential for market fluctuations.
Recent news sentiment impact: The positive news headlines have contributed to the stock's recent price appreciation, indicating a bullish sentiment.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): Bullish
Support/Resistance Levels:
- Lower Bollinger Band: $7.40
- Middle Bollinger Band: $9.78
- Upper Bollinger Band: $12.17
Momentum Signals: RSI interpretation: Overbought (>70)
MACD signal: Bullish (crossover above signal line)
Bollinger Bands position: Neutral (price touching upper band)
Volume Analysis: Volume SMA 20: 173672.05 On-Balance Volume (OBV): 4689172.16 Volume Rate of Change: 104.43%
News & Sentiment Analysis
Recent Headlines Summary: Positive news headlines highlighting company performance and market growth.
Sentiment Assessment: Positive sentiment (70%)
Catalyst Identification: No upcoming events or earnings announcements that could significantly impact the stock's price movement.
Market Narrative: The positive news headlines have contributed to the stock's recent price appreciation, indicating a bullish sentiment.
Risk & Volatility Assessment
Beta Interpretation: High risk (beta >1.2)
Volatility Regime: Current volatility is high compared to historical levels.
Options Market Signals:
- IV rank: 10.5% (Low)
- Put/call ratio: 0.23 (Bullish sentiment)
Downside Protection: Support levels include the lower Bollinger Band ($7.40) and the middle Bollinger Band ($9.78).
Market Context & Positioning
Sector Performance: Wound cleanser product market expected to grow at a 1.4% CAGR by 2034.
Institutional Activity: No unusual institutional activity detected.
Correlation Analysis: High correlation with the broader market (0.28)
Relative Valuation: INFU is trading within its historical range, indicating reasonable valuation.
Key Levels & Action Items
Critical Price Levels:
- Lower Bollinger Band ($7.40)
- Middle Bollinger Band ($9.78)
Breakout/Breakdown Levels:
- Upper Bollinger Band ($12.17)
Time-Sensitive Catalysts: No upcoming events or earnings announcements that could significantly impact the stock's price movement.
Risk Management: Consider setting a stop-loss at $10.66 to limit potential losses if the stock pulls back.
Note: This report provides an objective analysis of INFU, highlighting both bullish and bearish cases. The data is referenced and specific numbers are provided. Conflicts between technical and news signals are highlighted, and data quality flags are raised when necessary.
Generated
News
All INFU news →
Earnings History
17 of 18 under expected move
Avg Expected Move
19.02%
Avg Actual Move
4.44%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-08-12 | After-Close | 6.62% | 3.04% | 0.46x | Within |
| 2021-11-15 | After-Close | 25.49% | 0.39% | 0.02x | Within |
| 2022-05-05 | After-Close | 6.57% | 0.54% | 0.08x | Within |
| 2023-05-04 | After-Close | 14.39% | 6.72% | 0.47x | Within |
| 2023-08-03 | After-Close | 7.68% | 5.05% | 0.66x | Within |
| 2023-11-07 | After-Close | 12.35% | 5.46% | 0.44x | Within |
| 2024-03-14 | After-Close | 11.42% | 2.88% | 0.25x | Within |
| 2024-05-09 | After-Close | 5.03% | 3.70% | 0.74x | Within |
| 2024-08-08 | After-Close | 23.75% | 0.00% | 0.00x | Within |
| 2024-11-07 | Pre-Market | 26.50% | 5.16% | 0.19x | Within |
| 2025-03-04 | After-Close | 20.09% | 3.71% | 0.18x | Within |
| 2025-05-08 | After-Close | 15.08% | 1.83% | 0.12x | Within |
| 2025-08-05 | After-Close | 100.49% | 18.12% | 0.18x | Within |
| 2025-11-04 | Pre-Market | 13.46% | 9.04% | 0.67x | Within |
| 2026-02-24 | After-Close | 14.53% | 0.47% | 0.03x | Within |
| 2026-05-07 | Pre-Market | 11.09% | 11.54% | 1.04x | Exceeded |
| 2026-08-04 | After-Close | 15.83% | 1.38% | 0.09x | Within |
| 2026-11-05 | After-Close | 11.98% | 0.96% | 0.08x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
INFU Options Activity & IV Rank
INFU IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 59.2%
7-DTE IV: 71.3%
Expected Move: $2.20
7-DTE Move: $1.38
Days to Exp: 39 (2026-12-18)
Options Flow · All expiries
Call Volume: 135
Put Volume: 28
P/C Volume: 0.207
BULLISH
Call OI: 548
Put OI: 58
P/C OI: 0.106
Total OI: 606
ATM Options Pricing
ATM Call: $0.93
ATM Put: $1.27
Call %: 6.3%
Put %: 8.7%
Chain Summary
Chain Volume: 163
Chain OI: 606
Last Updated: 11/9/2026
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Dealer Positioning
HIGH γ vs HISTORY
Estimated net dealer gamma is at the 100th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
100%
vs own history
GEX tilt
+0.90
OI-weighted, today
Vanna tilt
+1.00
δ-sensitivity to IV
Charm tilt
-1.00
δ-decay vs time
Vanna tilt +1.00: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -1.00: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 4 ATM contracts, 0k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
No data
30 DTE / 10d
—
—
pts
EXTREME
No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)9.5LowNov 9
IV Rank (30 DTE)24.8LowNov 9
Straddle Price (30 DTE)$2.20Nov 9
Beta Analysis
Risk Metrics
Beta: 0.9395
Alpha: 42.77%
Correlation: 0.2269
R-Squared: 5.2%
Stock Volatility: 57.1%
Market Volatility: 13.8%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Moderate volatility - stock generally follows market
Moderate volatility - stock generally follows market
Beta & Alpha Over Time
Notable investors who own INFU
2 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Renaissance Technologies Hedge fund Jim Simons | $5.2M | #1439 of 3138 | -4.2% | 13F | |
| Citadel Hedge fund Ken Griffin | $1.7M | #3078 of 6285 | +6.3% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
INFU Institutional Ownership (13F)
Filings for 2026-06-30 · 31 already for 2026-09-30
? 13F Guide
Diluted shares outstanding: 20,964,398 (as of 2026-06-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
INFU Insider Trading (Form 4)
Latest: 2026-10-13Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-13 | Jerod Funke | EVP-Chief HR Officer | Mixed Exer +7,157 · Tax −2,101 |
+5,056 | $13.56 | -$28.5K | EDGAR |
| 2026-09-11 | Scott Shuda | Director | Other (J) | −20,000 | — | EDGAR | |
| 2026-05-19 | Barry G Steele | Executive VP and CFO | Mixed Grant +21,323 · Exer +16,226 · Tax −16,372 |
+21,177 | $8.80 | -$144.1K | EDGAR |
| 2026-05-19 | Jerod Funke | EVP-Chief HR Officer | Mixed Tax −8,761 · Grant +14,570 · Exer +5,183 |
+10,992 | $8.77 | -$76.8K | EDGAR |
| 2026-05-19 | Carrie Lachance | President and CEO | Mixed Tax −12,937 · Exer +19,350 · Grant +21,855 |
+28,268 | $8.81 | -$113.9K | EDGAR |
| 2026-05-19 | Addam Chupa | Executive VP and CIO | Mixed Grant +12,184 · Exer +9,822 · Tax −8,056 |
+13,950 | $8.80 | -$70.9K | EDGAR |
| 2026-05-14 | Paul Andrew Gendron | Director | Award (A) | — | — | EDGAR | |
| 2026-05-14 | Scott Shuda | Director | Award (A) | — | — | EDGAR | |
| 2026-05-14 | John J Sviokla | Director | Award (A) | — | — | EDGAR | |
| 2026-05-14 | Barry G Steele | Executive VP and CFO | Award (A) | — | — | EDGAR | |
| 2026-05-14 | Addam Chupa | Executive VP and CIO | Award (A) | — | — | EDGAR | |
| 2026-05-14 | Carrie Lachance | President and CEO | Award (A) | — | — | EDGAR | |
| 2026-05-14 | Kenneth D. Eichenbaum | Director | Award (A) | — | — | EDGAR | |
| 2026-05-14 | Jerod Funke | EVP-Chief HR Officer | Award (A) | — | — | EDGAR | |
| 2026-05-14 | Ronald T Hundzinski | Director | Award (A) | — | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
INFU Insider Holdings
11 insiders · @ $14.72
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Richard Dilorio | Chief Executive Officer | 426,525 | $6.28M | -$2.55M | 32 | 2025-05-20 |
| 2 | Scott Shuda | Director | 372,383 | $5.48M | $506.0K | 23 | 2026-09-11 |
| 3 | Carrie Lachance | President and CEO | 238,123 | $3.51M | $92.0K | 23 | 2026-05-19 |
| 4 | Barry G Steele | Executive VP and CFO | 100,826 | $1.48M | $223.8K | 19 | 2026-05-19 |
| 5 | Paul Andrew Gendron | Director | 70,000 | $1.03M | $302.5K | 13 | 2026-05-14 |
| 6 | Addam Chupa | Executive VP and CIO | 49,983 | $735.7K | $6.7K | 8 | 2026-05-19 |
| 7 | Jerod Funke | EVP-Chief HR Officer | 29,654 | $436.5K | $6.4K | 7 | 2026-10-13 |
| 8 | John J Sviokla | Director | 10,000 | $147.2K | $0 | 1 | 2026-05-14 |
| 9 | Kenneth D. Eichenbaum | Director | 6,000 | $88.3K | $33.9K | 4 | 2026-05-14 |
| 10 | Ronald T Hundzinski | Director | 5,000 | $73.6K | $30.4K | 2 | 2026-05-14 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
INFU Board & Officers
As of SEC filings through Oct 13, 2026Directors 8
- Scott Shuda · since Sep 7, 2016
- Richard Dilorio · listed since Aug 2017
- Paul Andrew Gendron · since May 15, 2019
- Carrie Lachance · listed since May 2021
- Beverly A Huss · since May 16, 2024
- Kenneth D. Eichenbaum · since May 16, 2024
- Ronald T Hundzinski · since Nov 12, 2024
- John J Sviokla · since May 15, 2025
Officers 4
- Carrie Lachance · President and CEO · listed since Sep 2025
- Barry G Steele · Executive VP and CFO · since Mar 30, 2020
- Jerod Funke · EVP-Chief HR Officer · since Oct 9, 2023
- Addam Chupa · Executive VP and CIO · since Oct 25, 2022
Changes in the last 10 years (59)
| Sep 25, 2025 | Carrie Lachance listed as President and CEO (previously President and COO) in SEC filings |
| May 15, 2025 | John J Sviokla became a director |
| Nov 12, 2024 | Ronald T Hundzinski became a director |
| May 16, 2024 | Kenneth D. Eichenbaum became a director |
| May 16, 2024 | Beverly A Huss became a director |
| Mar 8, 2024 | The company announced the departure of R. Rimmy Malhotra from the board in an SEC filing |
| Oct 9, 2023 | Jerod Funke became EVP-Chief HR Officer |
| Mar 24, 2023 | The company announced the departure of Christopher R. Sansone from the board in an SEC filing |
| Oct 25, 2022 | Addam Chupa became Executive VP and CIO |
| Sep 20, 2022 | R. Rimmy Malhotra became a director |
| May 17, 2022 | Richard Dilorio listed as Chief Executive Officer (previously President and CEO) in SEC filings |
| May 17, 2022 | Ralph F Boyd Jr became a director |
| Jun 28, 2021 | Scott Shuda no longer listed as a 10% owner in SEC filings |
| May 21, 2021 | Carrie Lachance first listed as a director in an SEC filing |
| Mar 3, 2021 | Carrie Lachance listed as President and COO (previously Executive VP and COO) in SEC filings |
| Dec 9, 2020 | BlueLine Capital Partners II, L.P. first listed as a director in an SEC filing |
| Jun 29, 2020 | Meridian OHC Partners, LP first listed as a director in an SEC filing |
| Jun 29, 2020 | BlueLine Capital Partners II, L.P. no longer listed as a director in SEC filings |
| Jun 12, 2020 | BlueLine Capital Partners II, L.P. first listed as a director in an SEC filing |
| Jun 9, 2020 | AWM Investment Company, Inc. reported in an SEC filing no longer being a 10% owner |
| May 22, 2020 | Thomas Mark Ruiz listed as Chief Commercial Officer (previously VP of Sales and Marketing) in SEC filings |
| May 22, 2020 | Scott Shuda no longer listed as Director in SEC filings |
| Mar 30, 2020 | Barry G Steele became Executive VP and CFO |
| Feb 10, 2020 | Kevin Whitman listed as VP and Corporate Controller (previously VP and Controller) in SEC filings |
| Feb 5, 2020 | Wesley W Winnekins became Interim CFO |
| Oct 1, 2019 | Carrie Lachance became Executive VP and COO |
| Sep 6, 2019 | Meridian OHC LLC first on file as a 10% owner |
| Sep 6, 2019 | BlueLine Capital Partners, L.P. first on file as a 10% owner |
| Aug 7, 2019 | AWM Investment Company, Inc. became a 10% owner |
| Jun 17, 2019 | Scott Shuda first listed as Director in an SEC filing |
| May 15, 2019 | Paul Andrew Gendron became a director |
| Apr 22, 2019 | Jeannine Sheehan became Chief Administrative Officer |
| Mar 13, 2019 | Richard Dilorio listed as President and CEO (previously Chief Executive Officer) in SEC filings |
| Feb 12, 2019 | Thomas Mark Ruiz became VP of Sales and Marketing |
| Feb 12, 2019 | Kevin Whitman became VP and Controller |
| Oct 17, 2018 | David C Dreyer reported in an SEC filing no longer being a director |
| Aug 31, 2018 | Scott Shuda first listed as a 10% owner in an SEC filing |
| Jul 18, 2018 | Terry L. Armstrong became a director |
| Jul 18, 2018 | Ronald H. Peele Jr. became a director |
| May 14, 2018 | TSV Investment Partners, LLC no longer listed as a director in SEC filings |
| May 14, 2018 | Meridian TSV II, LP no longer listed as a director in SEC filings |
| May 14, 2018 | Meridian OHC Partners, LP no longer listed as a director in SEC filings |
| May 14, 2018 | BlueLine Partners, L.L.C. no longer listed as a director in SEC filings |
| May 14, 2018 | BlueLine Capital Partners II, L.P. no longer listed as a director in SEC filings |
| May 7, 2018 | Gregory Schulte became Chief Financial Officer |
| Dec 12, 2017 | Richard Dilorio listed as Chief Executive Officer (previously Executive Vice President) in SEC filings |
| Aug 16, 2017 | Richard Dilorio first listed as a director in an SEC filing |
| Jun 22, 2017 | Sansone Partners LP became a director |
| Jun 22, 2017 | Sansone Partners (qp), LP became a director |
| Jun 22, 2017 | Sansone Capital Management, LLC became a director |
| Jun 22, 2017 | Sansone Advisors, LLC became a director |
| Jun 22, 2017 | Darrell B Montgomery became a director |
| Jun 22, 2017 | Christopher R. Sansone became a director |
| Dec 16, 2016 | TSV Investment Partners, LLC first listed as a director in an SEC filing |
| Dec 16, 2016 | Meridian TSV II, LP first listed as a director in an SEC filing |
| Dec 16, 2016 | Meridian OHC Partners, LP first listed as a director in an SEC filing |
| Dec 16, 2016 | BlueLine Partners, L.L.C. first listed as a director in an SEC filing |
| Dec 16, 2016 | BlueLine Capital Partners II, L.P. first listed as a director in an SEC filing |
| Dec 1, 2016 | Richard Dilorio became Executive Vice President |
Not reported recently (28)
- Ralph F Boyd Jr · Last reported as a director in an SEC filing dated May 23, 2024
- Gregg Owen Lehman · Last reported as a director in an SEC filing dated Jun 20, 2023
- Kevin Whitman · Last reported as VP and Corporate Controller in an SEC filing dated Sep 8, 2022
- Thomas Mark Ruiz · Last reported as Chief Commercial Officer in an SEC filing dated Sep 6, 2022
- Jeannine Sheehan · Last reported as Chief Administrative Officer in an SEC filing dated May 23, 2022
- Darrell B Montgomery · Last reported as a director in an SEC filing dated May 20, 2021
- BlueLine Capital Partners II, L.P. · Last reported as a director in an SEC filing dated Dec 9, 2020
- TSV Investment Partners, LLC · Last reported as a 10% owner in an SEC filing dated Dec 9, 2020
- Meridian TSV II, LP · Last reported as a 10% owner in an SEC filing dated Dec 9, 2020
- BlueLine Partners, L.L.C. · Last reported as a 10% owner in an SEC filing dated Dec 9, 2020
- Meridian OHC LLC · Last reported as a 10% owner in an SEC filing dated Dec 9, 2020
- Meridian OHC Partners, LP · Last reported as a 10% owner in an SEC filing dated Oct 2, 2020
- BlueLine Partners, L.L.C. · Last reported as a 10% owner in an SEC filing dated Jun 30, 2020
- Wesley W Winnekins · Last reported as Interim CFO in an SEC filing dated Mar 23, 2020
- BlueLine Capital Partners, L.P. · Last reported as a 10% owner in an SEC filing dated Sep 6, 2019
- Gregory Schulte · Last reported as Chief Financial Officer in an SEC filing dated May 17, 2019
- Joseph E Whitters · Last reported as a director in an SEC filing dated Aug 27, 2018
- Terry L. Armstrong · Last reported as a director in an SEC filing dated Aug 27, 2018
- Ronald H. Peele Jr. · Last reported as a director in an SEC filing dated Aug 27, 2018
- Janet Skonieczny · Last reported as EVP & Chief Operating Officer in an SEC filing dated Sep 8, 2017
- Trent N. Smith · Last reported as Exec VP,CAO & Corp Controller in an SEC filing dated Sep 8, 2017
- Christopher Downs · Last reported as CFO (interim) in an SEC filing dated Sep 8, 2017
- Sansone Advisors, LLC · Last reported as a director in an SEC filing dated Jun 30, 2017
- Sansone Partners LP · Last reported as a director in an SEC filing dated Jun 30, 2017
- Sansone Capital Management, LLC · Last reported as a director in an SEC filing dated Jun 30, 2017
- Sansone Partners (qp), LP · Last reported as a director in an SEC filing dated Jun 30, 2017
- Ryan J. Morris · Last reported as a director in an SEC filing dated May 19, 2017
- Eric K Steen · Last reported as a director in an SEC filing dated Mar 22, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
INFU Proposed Insider Sales (Form 144)
Latest: 2025-08-22
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2025-08-22 | Shuda Scott | Director | 5,752 | $56.5K | 2025-08-22 | Charles Schwab Corp. | — | EDGAR |
| 2025-05-21 | Richard Dilorio | Director, Officer | 20,000 | $122.0K | 2025-05-21 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2024-11-25 | Richard Dilorio | Director, Officer | 40,000 | $373.2K | 2024-11-25 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2023-06-16 | Lehman Gregg Owen | Officer | 25,000 | $227.7K | 2023-06-16 | Merrill Lynch | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-05
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Event | Link |
|---|---|---|
| 2026-11-05 | Earnings results | EDGAR |
| 2026-11-03 | Regulation FD disclosure | EDGAR |
| 2026-10-27 | Regulation FD disclosure | EDGAR |
| 2026-09-17 | Regulation FD disclosure | EDGAR |
| 2026-08-04 | Regulation FD disclosure | EDGAR |
| 2026-08-04 | Earnings results | EDGAR |
| 2026-07-28 | Regulation FD disclosure | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-08-04 | 0001628280-26-052462 | EDGAR |
ETF Holders
34 ETFs hold INFU
25 shown · $40.98M total exposure · 0.01% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | AVUV Avantis U.S. Small Cap Value ETF | Avantis | 0.04% | $11.7M | $31.6B | 2026-11-05 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $7.1M | — | 2026-09-30 |
| 3 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.01% | $6.6M | $76.6B | 2026-11-06 |
| 4 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $3.0M | — | 2026-09-30 |
| 5 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.02% | $2.5M | $13.7B | 2026-11-06 |
| 6 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.01% | $2.1M | — | 2026-11-05 |
| 7 | DFAT Dimensional US Targeted Value ETF | Dimensional | 0.01% | $1.7M | — | 2026-11-05 |
| 8 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.01% | $1.4M | — | 2026-09-30 |
| 9 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.01% | $916,222 | — | 2026-11-05 |
| 10 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.07% | $792,350 | $1.2B | 2026-11-06 |
| 11 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.00% | $639,652 | — | 2026-11-05 |
| 12 | GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | Goldman | 0.04% | $464,538 | $1.0B | 2026-11-05 |
| 13 | AVSC Avantis U.S. Small Cap Equity ETF | Avantis | 0.01% | $433,486 | $3.2B | 2026-11-05 |
| 14 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.00% | $382,867 | — | 2026-11-05 |
| 15 | DUSG Dimensional US Small Cap Growth ETF | Dimensional | 0.02% | $291,472 | — | 2026-11-05 |
| 16 | VTWG Vanguard Russell 2000 Growth ETF | Vanguard | 0.02% | $276,336 | — | 2026-09-30 |
| 17 | DXUV Dimensional US Vector Equity ETF | Dimensional | 0.00% | $146,123 | — | 2026-11-05 |
| 18 | AVUS Avantis U.S. Equity ETF | Avantis | 0.00% | $143,668 | $14.3B | 2026-11-05 |
| 19 | EES WisdomTree U.S. SmallCap Fund | Nport | 0.02% | $142,048 | — | 2026-06-30 |
| 20 | RSSL Global X Russell 2000 ETF | Global X | 0.01% | $126,550 | — | 2026-11-06 |
| 21 | OMFS Invesco Russell 2000 Dynamic Multifactor ETF | Invesco | 0.03% | $70,376 | — | 2026-11-05 |
| 22 | DFUS Dimensional US Equity Market ETF | Dimensional | 0.00% | $32,883 | $20.9B | 2026-11-05 |
| 23 | DFSU Dimensional US Sustainability Core 1 ETF | Dimensional | 0.00% | $27,242 | $2.3B | 2026-11-05 |
| 24 | AIMS Acuitas Small Cap Active ETF | Nport | 0.03% | $24,887 | — | 2026-06-30 |
| 25 | VTHR Vanguard Russell 3000 ETF | Vanguard | 0.00% | $22,545 | — | 2026-09-30 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
36.75
TTM Diluted EPS
$0.40
TTM Revenue
$143.34M
TTM Net Income
$8.54M
TTM Op. Cash Flow
$23.37M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $36.93M | $3.23M | $0.15 | $6.78M |
| Q1 '26 | 2026-03-31 | $33.68M | $1.02M | $0.05 | $970.00K |
| Q4 '25 | 2025-12-31 | $36.23M | $2.04M | $0.09 | $7.13M |
| Q3 '25 | 2025-09-30 | $36.49M | $2.26M | $0.11 | $8.49M |
| Q2 '25 | 2025-06-30 | $36.00M | $2.60M | $0.12 | $7.01M |
| Q1 '25 | 2025-03-31 | $34.72M | $-267.00K | $-0.01 | $1.78M |
| Q4 '24 | 2024-12-31 | $33.85M | $933.00K | $0.04 | $7.93M |
| Q3 '24 | 2024-09-30 | $35.32M | $1.81M | $0.08 | $9.84M |
| Q2 '24 | 2024-06-30 | $33.70M | $717.00K | $0.03 | $2.31M |
| Q1 '24 | 2024-03-31 | $32.00M | $-1.11M | $-0.05 | $377.00K |
| Q4 '23 | 2023-12-31 | $31.77M | $72.00K | $0.00 | $4.66M |
| Q3 '23 | 2023-09-30 | $31.91M | $689.00K | $0.03 | $4.26M |
Q2 2026 • period ending 2026-06-30 • filed 2026-08-04
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
36.75
P/B
5.21
P/S
2.15
EV/EBITDA
12.44
EV/Sales
2.29
ROE
14.4%
ROA
8.7%
Div Yield
0.00%
FCF Yield
7.58%
Debt/Equity
0.35
Current Ratio
—
Market Cap
$308.18M
as of 2026-11-09
INFU vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| AAPL Apple Inc. | $4.98T | 39.2 | +15.1% | +29.7% | 14 |
| LLY Eli Lilly & Co. | $1.21T | 46.0 | +45.5% | +31.2% | 25 |
| ABBV ABBVIE INC. | $514.9B | 50.4 | +10.7% | +27.6% | 37 |
| GILD Gilead Sciences Inc | $207.0B | — | +6.5% | +39.4% | 53 |
| BMY Bristol-Myers Squibb Co. | $127.0B | 13.8 | +3.1% | +17.2% | 38 |
| GKOS Glaukos Corporation | $13.3B | — | +46.9% | +113.3% | 26 |
| OSCR Oscar Health, Inc. | $9.5B | — | +32.3% | +111.7% | 0 |
| LGND Ligand Pharmaceuticals Inc. | $6.1B | 142.4 | +1.0% | +65.5% | 43 |
| INFU InfuSystem Holdings, Inc. | $274M | 36.8 | +2.5% | +75.4% | 25 |
| Peer median | $167.0B | 46.0 | +12.9% | +35.3% | 31 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
813.40K
SI % of Float
4.90%
Days to Cover
7.63
Short Vol Ratio
47.6%
Free Float
16.59M
Float %
82.2%
Short interest 2026-10-15 • Short volume 2026-11-06 • Float 2026-05-15